Rice Hall James & Associates LLC Grows Holdings in Simulations Plus, Inc. $SLP

Rice Hall James & Associates LLC increased its holdings in Simulations Plus, Inc. (NASDAQ:SLPFree Report) by 44.8% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 101,598 shares of the technology company’s stock after acquiring an additional 31,413 shares during the quarter. Rice Hall James & Associates LLC owned about 0.50% of Simulations Plus worth $1,201,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors also recently modified their holdings of the business. Raymond James Financial Inc. bought a new stake in Simulations Plus during the second quarter worth about $25,000. Quarry LP purchased a new stake in Simulations Plus in the third quarter worth about $28,000. PNC Financial Services Group Inc. increased its stake in shares of Simulations Plus by 59.3% during the first quarter. PNC Financial Services Group Inc. now owns 4,485 shares of the technology company’s stock valued at $53,000 after purchasing an additional 1,669 shares in the last quarter. Fifth Third Bancorp bought a new position in shares of Simulations Plus during the first quarter valued at approximately $54,000. Finally, Caitong International Asset Management Co. Ltd increased its stake in shares of Simulations Plus by 343.0% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 3,983 shares of the technology company’s stock valued at $73,000 after purchasing an additional 3,084 shares in the last quarter. 78.08% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

SLP has been the topic of a number of analyst reports. Weiss Ratings raised Simulations Plus from a “sell (d)” rating to a “sell (d+)” rating in a research report on Friday, July 10th. Craig Hallum lowered Simulations Plus from a “buy” rating to a “hold” rating and set a $18.50 price objective for the company. in a research report on Thursday, June 18th. Wall Street Zen cut Simulations Plus from a “buy” rating to a “hold” rating in a research note on Saturday, June 13th. TD Cowen dropped their target price on Simulations Plus from $19.00 to $16.00 and set a “hold” rating on the stock in a report on Friday, April 10th. Finally, William Blair cut Simulations Plus from an “outperform” rating to a “market perform” rating in a research note on Wednesday, June 17th. Seven research analysts have rated the stock with a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Reduce” and a consensus target price of $17.25.

Get Our Latest Analysis on Simulations Plus

Simulations Plus Stock Performance

Shares of Simulations Plus stock opened at $18.34 on Monday. The company has a 50-day simple moving average of $17.25 and a two-hundred day simple moving average of $15.44. The stock has a market capitalization of $371.02 million, a PE ratio of 45.85 and a beta of 1.30. Simulations Plus, Inc. has a 52-week low of $11.09 and a 52-week high of $21.01.

Simulations Plus (NASDAQ:SLPGet Free Report) last posted its quarterly earnings results on Thursday, July 9th. The technology company reported $0.30 EPS for the quarter, beating analysts’ consensus estimates of $0.23 by $0.07. Simulations Plus had a net margin of 9.88% and a return on equity of 13.50%. The firm had revenue of $21.89 million for the quarter, compared to analysts’ expectations of $20.90 million. As a group, equities research analysts forecast that Simulations Plus, Inc. will post 0.8 EPS for the current fiscal year.

Insider Buying and Selling at Simulations Plus

In other news, Director Walter S. Woltosz sold 4,177 shares of the business’s stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $18.44, for a total transaction of $77,023.88. Following the completion of the transaction, the director directly owned 3,202,131 shares of the company’s stock, valued at $59,047,295.64. The trade was a 0.13% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 19.10% of the stock is owned by insiders.

Simulations Plus Company Profile

(Free Report)

Simulations Plus, Inc (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company’s flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.

See Also

Institutional Ownership by Quarter for Simulations Plus (NASDAQ:SLP)

Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.